Home | Welcome to Contract Pharma   
Last Updated Saturday, April 25 2015

Print

Search Results for 'Financial Report: Alexion'

Search For:
Refine by Dates:
From: To:
Past 7 Days        Past 30 Days
Refine By Content:

Search Results:

Published April 24, 2015
Soliris sales up 6% Read More »
Published April 24, 2015
Product sales were up 13% in the quarter Read More »
Published April 24, 2015
Animal Health offsets lingering effects of patent expirations for Cymbalta and Evista Read More »
Published January 29, 2015
Soliris sales up 44% for the year Read More »
Published April 24, 2014
Solaris revenue up 67% in the quarter Read More »
By Gil Roth
Published January 30, 2014
Soliris sales continue to climb Read More »
Published July 25, 2012
Revenues up 48% in the quarter Read More »
Published July 21, 2011
Soliris sales jump 48% to $185.7 million. Read More »
Solaris revenue up 67% in the quarter Read More »


Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On